FDA Inspection 731057 — Veloxis Pharmaceuticals, Inc.

Veloxis Pharmaceuticals, Inc. — FEI 3008678603

The FDA completed an inspection of Veloxis Pharmaceuticals, Inc. on June 15, 2011 in Cary, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 15, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cary, NC (United States)

Additional Details

Sponsor, Contract Research Organization